Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association

O. Shamriz; S. H. Yahia; Y. Ramot; N. Agmon-Levin; Y. Tal

doi:10.1177/0961203319899985

Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association

O. Shamriz, S. H. Yahia, Y. Ramot, N. Agmon-Levin, Y. Tal^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Belimumab, an anti-B-lymphocyte stimulator monoclonal antibody, was recently approved for the treatment of systemic lupus erythematosus. Alopecia areata is characterized by an acute immune-mediated hair loss. Herein, we report on three adult systemic lupus erythematosus patients who developed alopecia areata in association with belimumab treatment. Alopecia areata was resolved in all three patients and belimumab was discontinued in two of them. Thus, in the current report, we explore the plausible link between alopecia areata and belimumab.

Original language	English
Pages (from-to)	426-430
Number of pages	5
Journal	Lupus
Volume	29
Issue number	4
DOIs	https://doi.org/10.1177/0961203319899985
State	Published - 1 Apr 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© The Author(s) 2020.

Keywords

Alopecia areata
belimumab
SLE
systemic lupus erythematosus

Access to Document

10.1177/0961203319899985

Cite this

@article{4f2691ea745d4673b64a63d9ca29224b,

title = "Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association",

abstract = "Belimumab, an anti-B-lymphocyte stimulator monoclonal antibody, was recently approved for the treatment of systemic lupus erythematosus. Alopecia areata is characterized by an acute immune-mediated hair loss. Herein, we report on three adult systemic lupus erythematosus patients who developed alopecia areata in association with belimumab treatment. Alopecia areata was resolved in all three patients and belimumab was discontinued in two of them. Thus, in the current report, we explore the plausible link between alopecia areata and belimumab.",

keywords = "Alopecia areata, belimumab, SLE, systemic lupus erythematosus",

author = "O. Shamriz and Yahia, {S. H.} and Y. Ramot and N. Agmon-Levin and Y. Tal",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2020.",

year = "2020",

month = apr,

day = "1",

doi = "10.1177/0961203319899985",

language = "אנגלית",

volume = "29",

pages = "426--430",

journal = "Lupus",

issn = "0961-2033",

publisher = "SAGE Publications Ltd",

number = "4",

}

TY - JOUR

T1 - Alopecia areata in patients with systemic lupus erythematosus treated with belimumab

T2 - a plausible association

AU - Shamriz, O.

AU - Yahia, S. H.

AU - Ramot, Y.

AU - Agmon-Levin, N.

AU - Tal, Y.

N1 - Publisher Copyright: © The Author(s) 2020.

PY - 2020/4/1

Y1 - 2020/4/1

N2 - Belimumab, an anti-B-lymphocyte stimulator monoclonal antibody, was recently approved for the treatment of systemic lupus erythematosus. Alopecia areata is characterized by an acute immune-mediated hair loss. Herein, we report on three adult systemic lupus erythematosus patients who developed alopecia areata in association with belimumab treatment. Alopecia areata was resolved in all three patients and belimumab was discontinued in two of them. Thus, in the current report, we explore the plausible link between alopecia areata and belimumab.

AB - Belimumab, an anti-B-lymphocyte stimulator monoclonal antibody, was recently approved for the treatment of systemic lupus erythematosus. Alopecia areata is characterized by an acute immune-mediated hair loss. Herein, we report on three adult systemic lupus erythematosus patients who developed alopecia areata in association with belimumab treatment. Alopecia areata was resolved in all three patients and belimumab was discontinued in two of them. Thus, in the current report, we explore the plausible link between alopecia areata and belimumab.

KW - Alopecia areata

KW - belimumab

KW - SLE

KW - systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85077700670&partnerID=8YFLogxK

U2 - 10.1177/0961203319899985

DO - 10.1177/0961203319899985

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 31924144

AN - SCOPUS:85077700670

SN - 0961-2033

VL - 29

SP - 426

EP - 430

JO - Lupus

JF - Lupus

IS - 4

ER -

Alopecia areata in patients with systemic lupus erythematosus treated with belimumab: a plausible association

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this